Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.
Summary of Consolidated Financial Results for the Six Months Ended September 30, 2021 (Based on Japanese GAAP)
November 5, 2021 | |||||||||||||||||||||||||||||||||||||
Company name: | CRESCO LTD. | ||||||||||||||||||||||||||||||||||||
Stock exchange listing: | Tokyo | ||||||||||||||||||||||||||||||||||||
Stock code: | 4674 | URL | https://www.cresco.co.jp/ | ||||||||||||||||||||||||||||||||||
Representative: | President, Executive Officer | Hiroyuki Nemoto | |||||||||||||||||||||||||||||||||||
Inquiries: | Director, Managing Executive Officer | Kazuo Sugiyama | TEL | +81-3-5769-8011 | |||||||||||||||||||||||||||||||||
Scheduled date to file Quarterly Securities Report: | November 8, 2021 | ||||||||||||||||||||||||||||||||||||
Scheduled date to commence dividend payments: | December 1, 2021 | ||||||||||||||||||||||||||||||||||||
Preparation of supplementary material on quarterly financial results: | No | ||||||||||||||||||||||||||||||||||||
Holding of quarterly financial results meeting: | Yes | (for analysts) | |||||||||||||||||||||||||||||||||||
(Amounts less than one million yen are rounded down) | |||||||||||||||||||||||||||||||||||||
1. Consolidated financial results for the six months ended September 30, 2021 (from April 1, 2021 to September 30, 2021) | |||||||||||||||||||||||||||||||||||||
(1) Consolidated operating results (cumulative) | Percentages indicate year-on-year changes | ||||||||||||||||||||||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | ||||||||||||||||||||||||||||||||||
owners of parent | |||||||||||||||||||||||||||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | ||||||||||||||||||||||||||||||
Six months ended September 30, 2021 | 21,061 | 9.7 | 2,017 | 47.6 | 2,223 | 20.5 | 1,606 | 22.8 | |||||||||||||||||||||||||||||
Six months ended September 30, 2020 | 19,203 | (0.1) | 1,366 | (20.8) | 1,844 | (2.7) | 1,308 | 14.9 | |||||||||||||||||||||||||||||
Earnings per share | Diluted earnings per share | ||||||||||||||||||||||||||||||||||||
Yen | Yen | ||||||||||||||||||||||||||||||||||||
Six months ended September 30, 2021 | 76.44 | - | |||||||||||||||||||||||||||||||||||
Six months ended September 30, 2020 | 62.34 | - | |||||||||||||||||||||||||||||||||||
(2) Consolidated financial position | |||||||||||||||||||||||||||||||||||||
Total assets | Net assets | Equity ratio | |||||||||||||||||||||||||||||||||||
Millions of yen | Millions of yen | % | |||||||||||||||||||||||||||||||||||
As of September 30, 2021 | 30,948 | 20,602 | 66.6 | ||||||||||||||||||||||||||||||||||
As of March 31, 2021 | 30,342 | 19,485 | 64.2 | ||||||||||||||||||||||||||||||||||
2. Cash dividends | |||||||||||||||||||||||||||||||||||||
Annual dividends per share | |||||||||||||||||||||||||||||||||||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Fiscal year-end | Total | |||||||||||||||||||||||||||||||||
Yen | Yen | Yen | Yen | Yen | |||||||||||||||||||||||||||||||||
Year ended March 31, 2021 | - | 18.00 | - | 20.00 | 38.00 | ||||||||||||||||||||||||||||||||
Year ending March 31, 2022 | - | 20.00 | |||||||||||||||||||||||||||||||||||
Year ending March 31, 2022 (Forecast) | - | 20.00 | 40.00 | ||||||||||||||||||||||||||||||||||
3. Forecast of consolidated financial results for the fiscal year ending March 31, 2022 (from April 1, 2021 to March 31, 2022) | |||||||||||||||||||||||||||||||||||||
Percentages indicate year-on-year changes | |||||||||||||||||||||||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | Earnings | |||||||||||||||||||||||||||||||||
owners of parent | per share | ||||||||||||||||||||||||||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % Millions of yen | % | Yen | ||||||||||||||||||||||||||||||
Full year | 42,400 | 6.8 | 3,850 | 10.5 | 4,200 | 2.4 | 2,850 | 8.2 | 135.54 | ||||||||||||||||||||||||||||
1
4. Notes | |||||||
(1) | Changes in significant subsidiaries during the six months ended September 30, 2021: | No | |||||
(2) | Application of special accounting methods for preparing quarterly consolidated financial statements: | No | |||||
(3) | Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements | ||||||
Changes in accounting policies due to revisions to accounting standards and other regulations: | Yes | ||||||
Changes in accounting policies due to other reasons: | No | ||||||
Changes in accounting estimates: | No | ||||||
Restatement of prior period financial statements: | No | ||||||
(4) | Number of issued shares (common shares) | ||||||
Total number of issued shares at the end of the period (including treasury shares) | |||||||
As of September 30, 2021 | 23,000,000 shares | As of March 31, 2021 | 23,000,000 shares | ||||
Number of treasury shares at the end of the period | |||||||
As of September 30, 2021 | 1,973,121 shares | As of March 31, 2021 | 1,978,723 shares | ||||
Average number of shares during the period (cumulative from the beginning of the fiscal year) | |||||||
Six months ended September 30, 2021 | 21,021,600 shares | Six months ended September 30, 2020 | 20,992,836 shares |
2
Quarterly consolidated financial statements
Quarterly consolidated balance sheets
(Thousands of yen) | |||
As of March 31, 2021 | As of September 30, 2021 | ||
Assets | |||
Current assets | |||
Cash and deposits | 11,039,932 | 10,353,620 | |
Notes and accounts receivable - trade | 7,855,304 | - | |
Notes and accounts receivable - trade, and contract assets | - | 7,901,051 | |
Electronically recorded monetary claims - operating | 15,608 | 20,919 | |
Securities | 459,292 | 193,060 | |
Money held in trust | 64,146 | 70,154 | |
Merchandise and finished goods | 37,315 | 36,824 | |
Work in process | 156,750 | 270,173 | |
Supplies | 1,655 | 36,742 | |
Other | 449,756 | 560,353 | |
Total current assets | 20,079,762 | 19,442,901 | |
Non-current assets | |||
Property, plant and equipment | 468,066 | 503,518 | |
Intangible assets | |||
Goodwill | 494,413 | 1,634,173 | |
Software | 556,142 | 505,667 | |
Other | 12,950 | 14,248 | |
Total intangible assets | 1,063,506 | 2,154,089 | |
Investments and other assets | |||
Investment securities | 6,704,112 | 6,843,764 | |
Other | 2,134,237 | 2,111,829 | |
Allowance for doubtful accounts | (107,209) | (107,209) | |
Total investments and other assets | 8,731,141 | 8,848,385 | |
Total non-current assets | 10,262,714 | 11,505,992 | |
Total assets | 30,342,477 | 30,948,894 | |
3
(Thousands of yen) | |||
As of March 31, 2021 | As of September 30, 2021 | ||
Liabilities | |||
Current liabilities | |||
Accounts payable - trade | 1,856,920 | 1,984,482 | |
Short-term borrowings | 100,000 | 130,000 | |
Current portion of long-term borrowings | 671,934 | 776,950 | |
Income taxes payable | 1,056,596 | 689,543 | |
Provision for bonuses | 1,457,806 | 1,487,634 | |
Provision for loss on order received | 7,861 | 12,224 | |
Other | 2,001,243 | 1,438,169 | |
Total current liabilities | 7,152,363 | 6,519,005 | |
Non-current liabilities | |||
Long-term borrowings | 1,142,515 | 1,065,040 | |
Long-term accounts payable - other | 52,746 | 52,701 | |
Retirement benefit liability | 2,432,926 | 2,631,608 | |
Asset retirement obligations | 71,696 | 72,353 | |
Other | 4,366 | 6,172 | |
Total non-current liabilities | 3,704,250 | 3,827,876 | |
Total liabilities | 10,856,613 | 10,346,881 | |
Net assets | |||
Shareholders' equity | |||
Share capital | 2,514,875 | 2,514,875 | |
Capital surplus | 3,363,262 | 3,369,109 | |
Retained earnings | 14,388,180 | 15,574,575 | |
Treasury shares | (2,207,691) | (2,199,723) | |
Total shareholders' equity | 18,058,626 | 19,258,836 | |
Accumulated other comprehensive income | |||
Valuation difference on available-for-sale securities | 1,427,859 | 1,340,559 | |
Foreign currency translation adjustment | 2,547 | 4,686 | |
Remeasurements of defined benefit plans | (3,169) | (2,070) | |
Total accumulated other comprehensive income | 1,427,236 | 1,343,175 | |
Total net assets | 19,485,863 | 20,602,012 | |
Total liabilities and net assets | 30,342,477 | 30,948,894 | |
4
Quarterly consolidated statements of income and quarterly consolidated statements of comprehensive income Quarterly consolidated statements of income
(Thousands of yen) | |||
Six months ended | Six months ended | ||
September 30, 2020 | September 30, 2021 | ||
Net sales | 19,203,466 | 21,061,881 | |
Cost of sales | 15,948,432 | 16,990,540 | |
Gross profit | 3,255,033 | 4,071,341 | |
Selling, general and administrative expenses | |||
Advertising expenses | 15,461 | 23,144 | |
Remuneration, salaries and allowances for directors (and | 807,863 | 894,028 | |
other officers) | |||
Provision for bonuses | 117,226 | 164,740 | |
Retirement benefit expenses | 16,551 | 27,079 | |
Legal welfare expenses | 119,363 | 140,657 | |
Recruiting expenses | 78,910 | 69,751 | |
Entertainment expenses | 8,461 | 7,798 | |
Rent expenses on land and buildings | 80,631 | 79,664 | |
Supplies expenses | 30,197 | 49,419 | |
Enterprise tax | 93,976 | 100,408 | |
Other | 519,593 | 496,897 | |
Total selling, general and administrative expenses | 1,888,235 | 2,053,591 | |
Operating profit | 1,366,798 | 2,017,749 | |
Non-operating income | |||
Interest income | 117,507 | 188,193 | |
Dividend income | 45,340 | 25,835 | |
Gain on sale of securities | 24,120 | 15,381 | |
Gain on valuation of securities | 11,824 | - | |
Gain on investments in money held in trust | 8,098 | 6,008 | |
Gain on valuation of derivatives | 276,093 | 5,506 | |
Subsidy income | 19,177 | 16,443 | |
Share of profit of entities accounted for using equity method | 5,768 | - | |
Other | 11,058 | 8,510 | |
Total non-operating income | 518,988 | 265,878 | |
Non-operating expenses | |||
Interest expenses | 3,461 | 3,209 | |
Foreign exchange losses | - | 8,069 | |
Investment advisory fees | 27,971 | 46,093 | |
Share of loss of entities accounted for using equity method | - | 1,494 | |
Other | 9,580 | 1,283 | |
Total non-operating expenses | 41,013 | 60,150 | |
Ordinary profit | 1,844,773 | 2,223,478 | |
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Cresco Ltd. published this content on 09 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 November 2021 02:12:06 UTC.